IP Library Assignment 028295/0491
Patent Assignment
Reel/Frame 028295/0491

Assignment of Assignor's Interest

Recorded: 2012-05-31 Pages: 5
Assignor
AMARIN PHARMA INC.
Executed: 2012-03-13
Assignee
AMARIN PHARMACEUTICALS IRELAND LIMITED
2 PEMBROKE HOUSE, UPPER PEMBROKE STREET 28-32, DUBLIN, 2, IRELAND
Covered Properties (23)
Methods of Treating Hypertriglyceridemia
Patent: 8,293,727 →
Application: 12/702,889 →
Publication: US 2010/0311834
Stable Pharmaceutical Composition and Methods of Using Same
Patent: 8,298,554 →
Application: 12/769,885 →
Publication: US 2010/0278879
Compositions and Methods for Lowering Triglycerides Without Raising Ldl-C Levels in a Subject on Concomitant Statin Therapy
Patent: 8,455,472 →
Application: 12/815,569 →
Publication: US 2011/0034555
Compositions and Methods for Treating and/or Preventing Cardiovascular Disease
Application: 13/040,977 →
Publication: US 2011/0218243
Methods of Treating Hypertriglyceridemia
Application: 13/198,221 →
Publication: US 2011/0288171
Pharmaceutical Compositions Comprising Epa and a Cardiovascular Agent and Methods of Using the Same
Application: 13/266,085 →
Publication: US 2012/0121698
Stable Pharmaceutical Composition and Methods of Using Same
Application: 13/266,374 →
Publication: US 2012/0100208
Compositions and Methods for Lowering Triglycerides
Patent: 8,410,086 →
Application: 13/272,520 →
Publication: US 2012/0035262
Methods of Treating Hypertriglyceridemia
Patent: 8,318,715 →
Application: 13/282,145 →
Publication: US 2012/0093924
Methods of Treating Hypertriglyceridemia
Patent: 8,314,086 →
Application: 13/284,408 →
Publication: US 2012/0039997
Methods of Treating Hypertriglyceridemia
Patent: 8,324,195 →
Application: 13/349,150 →
Publication: US 2012/0108663
Methods of Treating Hypertriglyceridemia
Patent: 8,293,728 →
Application: 13/349,153 →
Publication: US 2012/0108659
Methods of Treating Hypertriglyceridemia
Patent: 8,415,335 →
Application: 13/349,157 →
Publication: US 2012/0108660
Compositions and Methods for Lowering Triglycerides Without Raising Ldl-C Levels in a Subject on Concomitant Statin Therapy
Application: 13/359,114 →
Publication: US 2013/0012580
Methods of Treating Hypertriglyceridemia
Application: 13/403,694 →
Publication: US 2012/0156285
Compositions and Methods for Lowering Triglycerides in a Subject on Concomitant Statin Therapy
Patent: 8,710,041 →
Application: 13/403,699 →
Publication: US 2012/0232145
Methods of Treating Hypertriglyceridemia
Application: 13/404,666 →
Publication: US 2012/0157530
Compositions and Methods for Lowering Triglycerides
Application: 13/404,686 →
Publication: US 2012/0157531
Pharmaceutical Compositions Comprising Epa and a Cardiovascular Agent and Methods of Using the Same
Application: 13/418,591 →
Publication: US 2012/0172432
Methods of Treating Hypertriglyceridemia
Application: 61/173,755 →
Stable Pharmaceutical Composition and Methods of Using Same
Application: 61/173,763 →
Compositions and Methods for Treating and/or Preventing Cardiovascular Disease
Application: 61/310,443 →
Low Eructation Composition and Methods for Treating and/or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity
Application: 61/417,691 →
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 30, 2012
From: MANKU, MEHAR; OSTERLOH, IAN; WICKER, PIERRE; BRAECKMAN, RENE
To: AMARIN PHARMA, INC.
Reel/Frame 028291/0106 →
Assignment of Assignor's Interest May 30, 2012
From: OSTERLOH, IAN; WICKER, PIERRE; BRAECKMAN, RENE; SONI, PARESH
To: AMARIN PHARMA, INC.
Reel/Frame 028291/0046 →
Assignment of Assignor's Interest May 30, 2012
From: ROWE, JONATHAN
To: AMARIN PHARMA, INC.
Reel/Frame 028291/0077 →
Assignment of Assignor's Interest May 30, 2012
From: MANKU, MEHAR; OSTERLOH, IAN; WICKER, PIERRE; BRAECKMAN, RENE
To: AMARIN PHARMA, INC.
Reel/Frame 028291/0098 →
Security Agreement Dec 19, 2012
From: AMARIN PHARMACEUTICALS IRELAND LIMITED
To: BIOPHARMA SECURED DEBT FUND II HOLDINGS CAYMAN LP
Reel/Frame 029499/0087 →
Patent Security Assignment and Assumption Agreement Dec 20, 2017
From: BIOPHARMA SECURED DEBT FUND II HOLDINGS CAYMAN LP
To: CPPIB CREDIT EUROPE S.À R.L.
Reel/Frame 044956/0395 →
Security Interest Dec 21, 2017
From: AMARIN PHARMACEUTICALS IRELAND LIMITED
To: CPPIB CREDIT EUROPE S.À R.L.
Reel/Frame 044938/0257 →
Change of Address of Assignee Aug 27, 2020
From: AMARIN PHARMA, INC.
To: AMARIN PHARMA, INC.
Reel/Frame 053611/0324 →
Release of Security Interest Nov 19, 2020
From: CPPIB CREDIT EUROPE S.À R.L.
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 054484/0552 →
Assignment of Assignor's Interest May 15, 2024
From: SONI, PARESH; OSTERLOH, IAN
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 067418/0613 →